Steve Albers has been Corporate Vice President, Market Access and Public Affairs for Novo Nordisk, Inc. since May 2017.
Mr. Albers leads the US Market Access team in setting strategies and providing national leadership in communicating the value of all Novo Nordisk products to key payer customers.
Additionally, he directs the Public Affairs team on engagement with policy makers, educating them on the significance of the disease states that patients face as well as the business complexities that Novo Nordisk navigates. Mr. Albers is responsible for helping ensure that patients who need Novo Nordisk's medicines are able to get them.
Previously, Mr. Albers was Vice President of Market Access National Accounts, where he was responsible for payer marketing, contract strategy, pricing and account management for Novo Nordisk's portfolio of US medicines.
Mr. Albers has more than 20 years of experience within the medical and pharmaceutical industries. He joined Novo Nordisk in 2006 as District Business Manager in Minnesota achieving increasing levels of responsibility in the Sales and Market Access organization. He spent almost five years in Novo Nordisk's global headquarters in Denmark as Senior Global Marketing Director for Market Access before he was appointed Vice President of Global Market Access.
Prior to joining Novo Nordisk, Mr. Albers was a regional account manager for Serono Inc., a biotechnology company acquired by Merck. Before that, he worked at Takeda Pharmaceuticals America in various sales and account management roles of increasing responsibility.
He holds a bachelor's degree in biology from Concordia College in Minnesota.